India’s 1st COVID-19 Vaccine Candidate “Covaxin” Approved For Human Trials

India’s 1st COVID-19 Vaccine Candidate “Covaxin” Approved For Human Trials

Fossbytes

Published

Hyderabad-based Bharat Biotech has developed a potential vaccine to combat the Covid-19 disease. The vaccine is named Covaxin and represents India’s effort in curbing down the spread of Coronavirus that has ravaged countries across the globe. Covaxin contains a weakened version of the SARS-CoV-2 virus (Coronavirus) which will be injected into the patient’s body to […]

The post India’s 1st COVID-19 Vaccine Candidate “Covaxin” Approved For Human Trials appeared first on Fossbytes.

Full Article